Science Signaling Podcast for 18 October 2016: ALK combination therapies for lung cancer

See allHide authors and affiliations

Science Signaling  18 Oct 2016:
Vol. 9, Issue 450, pp. pc20
DOI: 10.1126/scisignal.aal0140

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


This Podcast features an interview with Eric Haura, author of a Research Resource that appears in the 18 October 2016 issue of Science Signaling, about using network biology to identify potential targets for combination therapies for treating lung cancers that have increased activity of the tyrosine kinase ALK.

Listen to Podcast

View Full Text

Stay Connected to Science Signaling